← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Tel-Aviv Sourasky Medical Center
Tel Aviv
$2,647,577
Total funding
3
Grants
Funding over time
peak $483.4K · FY2005–16$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,647,577 · 3
By mechanism
R01$2,360,183 · 2
R21$287,394 · 1
Investigators at Tel-Aviv Sourasky Medical Center
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
In situ Redirection of T cell Specificity and Imaging of Targeted CAR Expression.$483,404
R01 · FY2016 · EB
In situ Redirection of T cell Specificity and Imaging of Targeted CAR Expression.$461,820
R01 · FY2015 · EB
In situ Redirection of T cell Specificity and Imaging of Targeted CAR Expression.$458,203
R01 · FY2013 · EB
In situ Redirection of T cell Specificity and Imaging of Targeted CAR Expression.$426,075
R01 · FY2014 · EB
Ambulatory Monitoring of Near Falls: A Novel Measure of Fall Risk$144,710
R21 · FY2010 · AG
Ambulatory Monitoring of Near Falls: A Novel Measure of Fall Risk$142,684
R21 · FY2011 · AG
Gait instability in the elderly with increased fall risk$137,700
R01 · FY2005 · AG
Gait instability in the elderly with increased fall risk$134,464
R01 · FY2006 · AG
Gait instability in the elderly with increased fall risk$130,564
R01 · FY2007 · AG
Gait instability in the elderly with increased fall risk$127,953
R01 · FY2008 · AG